title: Pheochromocytomas: detection with 18F DOPA whole body PET--initial results..
abstract: OBJECTIVE
  To evaluate fluorine 18 ((18)F) dihydroxyphenylalanine (DOPA) whole-body positron emission tomography (PET) as a biochemical imaging approach for detection of pheochromocytomas.
  
  
  METHODS
  (18)F DOPA PET and magnetic resonance (MR) imaging were performed in 14 consecutive patients suspected of having pheochromocytomas (five sporadic, nine with von Hippel-Lindau disease); metaiodobenzylguanidine (MIBG) scintigraphy was performed in 12 of these patients. The individual imaging findings were assessed in consensus by specialists in nuclear medicine and radiologists blinded to the results of the other methods. The findings of the functional imaging methods were compared with those of MR imaging, the reference standard. Histologic verification could be obtained in eight patients with nine tumors.
  
  
  RESULTS
  Seventeen pheochromocytomas (11 solitary, three bifocal; 14 adrenal, three extraadrenal) were detected with MR imaging. (18)F DOPA PET and MR imaging had concordant results in all 17 tumors. In contrast, MIBG scintigraphy had false-negative results in four patients with three adrenal tumors smaller than 2 cm and one extraadrenal tumor with a diameter of 3.6 cm. On the basis of these data, sensitivities of 100% for (18)F DOPA PET and of 71% for MIBG scintigraphy were calculated. Specificity was 100% for both procedures.
  
  
  CONCLUSIONS
  (18)F DOPA PET is highly sensitive and specific for detection of pheochromocytomas and has potential as the functional imaging method of the future.
authors.affiliation: Divisions of Nuclear Medicine, Department of Radiology, Albert-Ludwigs University, Freiburg, Germany. hoegerle@ukl.uni-freiburg.de
authors.forename: Stefan
authors.initials: S
authors.lastname: Hoegerle
authors.forename: Egbert
authors.initials: E
authors.lastname: Nitzsche
authors.forename: Carsten
authors.initials: C
authors.lastname: Altehoefer
authors.forename: Nadir
authors.initials: N
authors.lastname: Ghanem
authors.forename: Tanja
authors.initials: T
authors.lastname: Manz
authors.forename: Ingo
authors.initials: I
authors.lastname: Brink
authors.forename: Martin
authors.initials: M
authors.lastname: Reincke
authors.forename: Ernst
authors.initials: E
authors.lastname: Moser
authors.forename: Hartmut P H
authors.initials: HP
authors.lastname: Neumann
mesh_terms: D000293:Adolescent; D000310:Adrenal Gland Neoplasms / Q000000981:diagnostic imaging*; D000328:Adult; D000368:Aged; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives*; D005260:Female; D005462:Fluorine Radioisotopes; D006801:Humans; D008297:Male; D008875:Middle Aged; D010673:Pheochromocytoma / Q000000981:diagnostic imaging*; D012680:Sensitivity and Specificity; D014055:Tomography, Emission-Computed; D014915:Whole-Body Counting
chemical_list: D005462:Fluorine Radioisotopes; C043437:fluorodopa F 18; D004295:Dihydroxyphenylalanine